Bay Area/ San Francisco

Cannabis Marketed in SF Shops For Pain And Sleep Despite Lack of Clinical Evidence: UCSF

AI Assisted Icon
Published on November 09, 2025
Cannabis Marketed in SF Shops For Pain And Sleep Despite Lack of Clinical Evidence: UCSFSource: Unsplash

Walk into a Bay Area dispensary looking for help with an aching back or a restless night, and odds are the person behind the counter will steer you to a lotion or a gummy. A new UCSF study says that’s common — and that the advice often leans on personal experience more than clinical evidence. Posing as customers, researchers heard specific product and strain tips in dozens of shops, raising the question of how well retail guidance matches what the science actually supports, even as more Californians turn to cannabis for relief and clinicians say the evidence remains uneven.

How The Study Worked — And What Staff Suggested

Researchers ran “secret‑shopper” visits to 35 of the 42 licensed dispensaries in San Francisco and Alameda counties, documenting how staff recommended products, doses and strains. In findings published in the journal Cannabis, budtenders most often pointed to topicals for pain (about 77%) and edibles for sleep (about 60%).

Advice Runs On Anecdote

Observers noted that many suggestions leaned on personal use or other shoppers’ stories rather than clinical studies. As reported by the San Francisco Chronicle, most staff offered no scientific explanation when recommending edibles for sleep, and a majority of those who suggested sleep products favored indica strains.

What The Evidence Actually Says

Broad reviews of cannabis research are mixed and vary by condition and product type. A 2025 living systematic review updated on PubMed found inconsistent benefits for chronic pain across randomized trials and observational studies, and limited evidence for sleep disorders — with effects differing by formulation and cannabinoid ratios (the living review).

Researchers Want Better Data — And Training

The UCSF team says clinical studies should zero in on the product types budtenders most often promote — topical preparations for pain and edibles for sleep — and calls for structured training so retail staff can separate anecdote from evidence. Aligning research questions with what customers actually use could help narrow the gap between retail practice and medical knowledge, the paper argues, and dispensary workers could use clearer guidance (Cannabis).

Shopping? Keep This In Mind

Clinicians and the study’s authors caution that a recommendation across the counter isn’t the same as medical advice, especially for people on other medications or living with chronic conditions. Study co‑author Dr. Pam Ling told the San Francisco Chronicle that people often "extrapolate from the limited studies" — a reminder to check with a health care provider before leaning on cannabis for recurring pain or sleep issues.

For now, the takeaway is straightforward: dispensary staff are advising customers on health problems in clear, repeatable ways, but the science behind many of those patterns is still catching up. That mismatch points to an immediate research agenda — and a potential role for standardized education in retail settings so shoppers get safer, more evidence‑aware guidance.